Veeva Systems Inc.

NYSE:VEEV

Medical - Healthcare Information Services

Healthcare
$277.20 -1.83%

-$2.83 today

Market cap
$44.88B
Beta
0.95
P/E (TTM)
26.4
EPS (TTM)
$5.76
52W Low $148.05High $310.50

Volume 2.74M

Average 3.01M

VEEV Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Veeva Systems Inc.NYSE: VEEV

Research & Development · Q2 FY2027 · quarter ended Jul 2026

Research & development growth accelerates

Q2 FY2027 research & development of $222.92M rose 15.7% year over year, ahead of the +12.5% change in trailing-twelve-month research & development. Sequentially, it rose 7.0% from the prior quarter. Over 3 fiscal years it compounded at +13.8% a year.

Context

  • Research & development amounted to 24.0% of revenue in FY2026, down 1.2 pp from a year earlier.
  • Research & development increased in 3 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +15.7% holds above the trailing-twelve-month pace of +12.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJul 2026
$222.92M+7.0% QoQ
Last fiscal yearJan 2026
$767.39M+10.7% YoY
LTMJul 2026
$821.92M+12.5% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+15.7%——
1 year+10.7%——
3-year CAGR+13.8%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2026
767.39M USD
Year-over-year change
+10.7%
4-year CAGR
+19.0%

Research & Development vs competitors

How VEEV compares with its peers on the latest reported figures

  • VEEV's LTM Jul 2026 research & development of $821.92M is the highest of the 5 companies compared; the peer median is $103.34M.
  • Its year-over-year change of +12.5% is the 2nd highest of 4, against a peer median of +7.4%.
  • Research & development amounts to 23.8% of revenue for VEEV, versus a peer median of 20.1%.
VEEV Competitors Peer median
Research & Development for VEEV and competitors
Company Period LTM YoY 3-year CAGR% of revenue
VEEVVeeva Systems Inc.LTM Jul 2026$821.92M +12.5%+13.8%23.8%
SDGRSchrödinger, Inc.LTM Sep 2026$160.31M -11.5%+11.1%59.6%
DOCSDoximity, Inc.LTM Sep 2026$154.14M +47.9%+17.7%23.3%
HSTMHealthStream, Inc.LTM Mar 2026$52.54M +7.4%+4.8%16.9%
IQVIQVIA Holdings Inc.LTM Jun 2026$0 ——0.0%
Peer median (excluding VEEV) $103.34M+7.4%+11.1%20.1%

Competitors are the stored peer set for VEEV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Jan 2022
FY2023
Jan 2023
FY2024
Jan 2024
FY2025
Jan 2025
FY2026
Jan 2026
Revenue1.85B2.16B2.36B2.75B3.2B
Cost of Revenue503.68M609.41M677.29M699.64M782.02M
Gross Profit1.35B1.55B1.69B2.05B2.41B
Gross Margin72.8%71.7%71.3%74.5%75.5%
Research & Development382.04M520.28M629.03M693.08M767.39M
Selling, General & Admin459.57M566.29M628.02M662.47M729.54M
Operating Expenses841.6M1.09B1.26B1.36B1.5B
Depreciation & Amortization27.45M29.12M32.63M39.38M50.47M
EBITDA539.76M538.22M620.65M958.76M1.24B
EBITDA Margin29.2%25.0%26.3%34.9%39.0%
Operating Income505.5M459.09M429.33M691.44M916.37M
Operating Margin27.3%21.3%18.2%25.2%28.7%
Interest Income14.73M45.86M133.75M207.99M0
Interest Expense00000
Other Income / Expenses6.82M50.01M158.69M227.95M278.14M
Income Before Tax512.31M509.1M588.02M919.38M1.19B
Pre-Tax Margin27.7%23.6%24.9%33.5%37.4%
Income Tax Expense84.92M21.39M62.32M205.24M285.6M
Net Income427.39M487.71M525.71M714.14M908.91M
Net Margin23.1%22.6%22.2%26.0%28.4%
EPS (Basic)2.793.143.274.415.55
EPS (Diluted)2.633.003.224.325.44
Weighted Avg Shares153.25M155.39M160.53M161.88M163.67M
Weighted Avg Shares (Diluted)162.28M162.44M163.49M165.23M167M

Veeva Systems Inc.

NYSE:VEEV

Intrinsic Alpha fair value

Locked

Current Price

$277.20

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.